GW Pharmaceuticals Plc (GWPH)

166.19
1.50 0.88
NASDAQ : Health Technology
Prev Close 167.66
Open 168.37
Day Low/High 165.50 / 168.72
52 Wk Low/High 90.14 / 196.00
Volume 246.67K
Avg Volume 368.60K
Exchange NASDAQ
Shares Outstanding 30.72M
Market Cap 5.30B
EPS -9.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

9 Speculative Plays for Investors Wanting Cannabis Exposure

9 Speculative Plays for Investors Wanting Cannabis Exposure

Five top marijuana stocks and four CBD plays in this speculative space.

2 Hemp Stocks for Investors Looking for Something Different

2 Hemp Stocks for Investors Looking for Something Different

You may want to check out GW Pharmaceuticals and Elixinol Global Limited.

Melius Research Launches Cannabis Industry Coverage

Melius Research Launches Cannabis Industry Coverage

In its first report on cannabis companies, Melius says prices are high.

GW Pharmaceuticals Is Ready to Rally More: How to Trade This Cannabis Stock

GW Pharmaceuticals Is Ready to Rally More: How to Trade This Cannabis Stock

My trading strategy for GWPH whether you are currently long or want to be.

Jim Cramer: My Best Stock Picks for Cannabis and China

Jim Cramer: My Best Stock Picks for Cannabis and China

And why I won't recommend any other stocks in these markets, right now.

Why Canada Rules as a Haven for Listing Cannabis Companies

Why Canada Rules as a Haven for Listing Cannabis Companies

The main reason most cannabis-related concerns head north to list their shares is banking.

Farm Bill's Hemp Legalization Is Poised to Boost These 2 Stocks

Farm Bill's Hemp Legalization Is Poised to Boost These 2 Stocks

Despite the current stock market, investors are still looking for ways to play the new legalization of hemp.

GW Pharmaceuticals Is Poised to Rally to New Highs, Risk Defined

GW Pharmaceuticals Is Poised to Rally to New Highs, Risk Defined

A potential great pipeline but let's check the charts.

Check Out These Stocks as Canada Is About to Be Smokin' Hot

Check Out These Stocks as Canada Is About to Be Smokin' Hot

On Wednesday, Canada becomes the first major economy to legalize the recreational use of cannabis.

Canopy Growth and 4 Other Cannabis Stocks That Look Good Here

Canopy Growth and 4 Other Cannabis Stocks That Look Good Here

These stocks offer some diversification or unique features in the legal-weed space.

Down the Marijuana Rabbit Hole: 5 Companies to Consider

It's too easy to lump all cannabis-related stocks into the moniker "marijuana." Like many other sectors, there are differentiators underneath the same way we see in semiconductors or retail or even energy.  As you go down the marijuana rabbit hole, ...

Legalized Recreational Marijuana Won't Kill Medical Marijuana

Legalized Recreational Marijuana Won't Kill Medical Marijuana

Sales trends and the potential for stronger versions of prescription cannabis offer medical marijuana providers hope.

Insys Therapeutics Is a Pretend Cannabis Stock

Insys Therapeutics Is a Pretend Cannabis Stock

It is time for investors to start differentiating between the Good, the Bad and the Ugly in cannabis stocks.

FDA Approval Puts GW Pharma, Three Other Cannabis-Related Names in the Spotlight

FDA Approval Puts GW Pharma, Three Other Cannabis-Related Names in the Spotlight

The milestone approval of Epidiolex bodes well for cannabis-based drug stocks GW Pharma, Nemus, Zynerba and Insys.

Seven U.S. Stocks Offering Cannabis Exposure

Seven U.S. Stocks Offering Cannabis Exposure

While cannabis remains illegal on a federal level, these seven names are making early inroads into the growing industry.

Jim Cramer: These 4 Cold Stocks of Once-Hot Companies Could Reignite

Jim Cramer: These 4 Cold Stocks of Once-Hot Companies Could Reignite

It's important to know the difference between broken stocks and broken companies.

The Market Is Finally Rewarding Stock Picking

The Market Is Finally Rewarding Stock Picking

The game plan is to spot the charts that have more room to run.

Here Is the Buzz on My Under-the-Radar Top ETF Pick for 2018

Here Is the Buzz on My Under-the-Radar Top ETF Pick for 2018

Look for this name to jump quickly in popularity in 2018 as investors players search for a convenient way to play the marijuana niche.

President Trump Looks Set for a Major Victory on Tax Reform: Market Recon

President Trump Looks Set for a Major Victory on Tax Reform: Market Recon

Party leaders will have to work toward merging the two versions of tax reform into one final bill.

Enjoy the Holiday Trading While It Lasts

Enjoy the Holiday Trading While It Lasts

Market momentum goes on a rampage.

Fund Manager High On Marijuana, Zinc as Shelters in Pullback

Fund Manager High On Marijuana, Zinc as Shelters in Pullback

Growth is almost guaranteed in these two areas, says James McDonald of Index Strategy Advisors.

Rev's Forum: Stock Pickers Have Some Opportunities

Rev's Forum: Stock Pickers Have Some Opportunities

But the buyers are still unable to produce sustained momentum.

Cramer: How Do You Play This Answer to the Opiate Epidemic?

Cramer: How Do You Play This Answer to the Opiate Epidemic?

GW Pharma could be the answer to an opiate addiction that isn't understood.

Jim Cramer Says Own Salesforce.com, Regeneron, First Solar

Jim Cramer Says Own Salesforce.com, Regeneron, First Solar

TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer says Macy's should benefit from the cold weather and energy stocks are still 'too dangerous' to put money into.

Jim Cramer Fields Questions From Viewers Including Henry Blodget

Jim Cramer Fields Questions From Viewers Including Henry Blodget

TheStreet's Jim Cramer tackled viewer questions on the economy from the NYSE Wednesday. His first viewer question was from Henry Blodget, an investor and CEO of Business Insider.

Cramer: Markets to Dip for a Few Weeks When the Fed Raises Rates

Cramer: Markets to Dip for a Few Weeks When the Fed Raises Rates

Jim Cramer answers viewers' Twitter (TWTR) questions from the floor of the New York Stock Exchange.

Here's What's Driving Biotech

And it's not the favorable macroeconomic climate.

That Was the Week That Was

That Was the Week That Was

Let's review.